News & Events
-
Congressional Testimony 2001
FDA Statements
-
October
- 10/10/2001
Federal Food Safety System
Bernard Schwetz, D.V.M, Ph.D., before the Senate Committee on Governmental Affairs, Subcommittee on Oversight of Government Management, Restructuring, and the District of Columbia
-
-
September
- 09/05/2001
Health Fraud
William K. Hubbard, before the Senate Committee on Consumer Affairs, Foreign Commerce, and Tourism
-
-
July
- 07/24/2001
Prescription Drug Promotion
Nancy M. Ostrove, Ph.D, before the Senate Committee on Consumer Affairs, Foreign Commerce, and Tourism
-
-
June
- 06/20/2001
Availability of Investigational Drugs for Compassionate Use
Robert J. Temple, M.D., before the House Committee on Government reform - 06/13/2001
Recent Developments Which May Impact Consumer Access to, and Demand for, Pharmaceuticals
Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health - 06/13/2001
Importation of Drugs into the United States
William K. Hubbard, before the House Committee on Energy and Commerce, Subcommittee on Health
-
-
May
- 05/24/2001
Human Tissue Banking
Kathryn C. Zoon, Ph.D, before the Senate Committee on Government Affairs, Permanent Subcommittee on Health - 05/24/2001
Implementation of Provisions of the Drug Price Competition and Patent Term Restoration Act of 1984
Gary Buehler, R.Ph., before the Senate Committee on the Judiciary - 05/10/2001
Challenges FDA faces in the New Century
Bernard Schwetz, D.V.M., Ph.D., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, and Related Agencies - 05/08/2001
Implementation of the Pediatric Exclusivity Provisions
Janet Woodcock, M.D., before the Committee on Health, Education, Labor, and Pensions - 05/03/2001
FDA's Progress/Success in Implementing the Food and Drug Administration Modernization Act of 1997 (FDAMA or Modernization Act)
Linda Suydam, D.P.A., before the House Committee on Energy and Commerce
-
-
April
- 04/26/2001
Concerns Regarding a Potential Link Between Vaccines and Autism
Karen Midthun, M.D., before the House Committee on Government Reform - 04/04/2001
BSE
Stephen Sundlof, D.V.M., Ph.D., before the Senate Committee on Commerce, Science, and Transportation, Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism
-
-
March
- 03/28/2001
FDA's Role in the Use of Cloning Technology as a Cause for Public Health Concern
Kathryn C. Zoon, Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 03/20/2001
FDA's Progress with Dietary Supplements
Joseph A. Levitt, Esq., before the House Committee on Government Reform - 03/08/2001
Challenges of the Next Century
Bernard Schwetz, D.V.M., Ph.D., before the House Committee on Appropriations
-
-
-